Incidental detection of non‐melanoma neoplasms in sentinel lymph node biopsy for melanoma staging: A retrospective case series
Journal of Cutaneous Pathology · 2024
DOI: 10.1111/cup.14725 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Cutaneous Pathology, 2024. Verfasst von Meghana Agni und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology and Laboratory Medicine, NorthShore University Health System/Endeavor Health, Evanston, Illinois, USA. Hauptthemen laut MEDLINE: Sentinel Lymph Node Biopsy, Melanoma, Incidental Findings, Skin Neoplasms. Die Arbeit nennt 24 Literaturangaben.
Abstract (Originalsprache)
Background
Patients with malignant melanoma have an increased risk of developing secondary hematologic malignancy, and patients with hematologic malignancies have an increased risk of developing melanoma. Rarely, sentinel lymph node biopsies (SLNBs) collected for melanoma staging might harbor lymphoma or even carcinoma, which may represent a second primary malignancy (SPM). Biopsied lymph node(s) might serve as the first site of recognition for a SPM. Yet, there has been little systematic investigation regarding the characteristics of incidental SPMs detected on SLNB for melanoma staging.
Methods
A series of cases of lymphomas and carcinomas were detected incidentally during SLNB for melanoma staging from two tertiary academic centers between 2000 and 2021.
Results
Fifteen cases of incidentally detected SPMs were reviewed, comprising 12 lymphomas and three carcinomas. The most common incidentally detected second malignancy was chronic lymphocytic leukemia/small lymphocytic lymphoma (60%, 9/15). There were three cases of incidentally detected metastatic carcinoma. Of all incidentally detected malignancies, 2/3 carcinomas and 4/12 lymphomas represented first‐time diagnoses of SPM in a melanoma patient. Forty percent of cases (6/15) also harbored metastatic melanoma in the sentinel lymph node.
Conclusions
It is possible to incidentally detect SPMs in SLNBs for melanoma staging. Early detection of SPMs in melanoma patients has implications for the treatment of both incidental SPM and melanoma.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pathology and Laboratory Medicine, NorthShore University Health System/Endeavor Health, Evanston, Illinois, USA.
- Department of Pathology, University of Chicago, Chicago, Illinois, USA.
- Department of Pathology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
- Department of Microbiology and Immunology, Geisel School of Medicine at Dartmouth, Lebanon, New Hampshire, USA.
- Department of Dermatology, University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA.
ORCID-Profile: Meghana Agni, Eleonora Fiorletta Quiroga
Zitieren
APA
Agni, M., Fiorletta Quiroga, E., Stevanovic, M., Venkataraman, G., & Shalin, S. C. (2024). Incidental detection of non‐melanoma neoplasms in sentinel lymph node biopsy for melanoma staging: A retrospective case series. Journal of Cutaneous Pathology. https://doi.org/10.1111/cup.14725
Vancouver
Agni M, Fiorletta Quiroga E, Stevanovic M, Venkataraman G, Shalin SC. Incidental detection of non‐melanoma neoplasms in sentinel lymph node biopsy for melanoma staging: A retrospective case series. Journal of Cutaneous Pathology. 2024. doi:10.1111/cup.14725
BibTeX
@article{Agni2024,
author = {Agni, Meghana and Fiorletta Quiroga, Eleonora and Stevanovic, Mirjana and Venkataraman, Girish and Shalin, Sara C},
title = {Incidental detection of non‐melanoma neoplasms in sentinel lymph node biopsy for melanoma staging: A retrospective case series},
journal = {Journal of Cutaneous Pathology},
year = {2024},
doi = {10.1111/cup.14725}
}
EUVIMED